Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder

被引：355

作者：

Fukagawa, Masafumi ^{[1
]}

Yokoyama, Keitaro ^{[1
]}

Koiwa, Fumihiko ^{[1
]}

Taniguchi, Masatomo ^{[1
]}

Shoji, Tetsuo ^{[1
]}

Kazama, Junichiro James ^{[1
]}

Komaba, Hirotaka ^{[1
]}

Ando, Ryoichi ^{[1
]}

Kakuta, Takatoshi ^{[1
]}

Fujii, Hideki ^{[1
]}

Nakayama, Msasaaki ^{[1
]}

Shibagaki, Yugo ^{[1
]}

Fukumoto, Seiji ^{[2
]}

Fujii, Naohiko ^{[1
]}

Hattori, Motoshi ^{[1
]}

Ashida, Akira ^{[1
]}

Iseki, Kunitoshi ^{[1
]}

Shigematsu, Takashi ^{[1
]}

Tsukamoto, Yusuke ^{[1
]}

Tsubakihara, Yoshiharu ^{[1
]}

Tomo, Tadashi ^{[1
]}

Hirakata, Hideki ^{[1
]}

Akizawa, Tadao ^{[1
]}

机构：

[1] Japanese Soc Dialysis Therapy, Tokyo, Japan

[2] Japanese Soc Nephrol, Tokyo, Japan

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2013年 / 17卷 / 03期

关键词：

Chronic kidney disease-Mineral and Bone Disorders; Clinical practice guideline; Parathyroid hormone; Serum Calcium; Serum phosphorus; Vascular calcification; CHRONIC-RENAL-FAILURE; CORONARY-ARTERY CALCIFICATION; GROWTH-FACTOR; 23; ACTIVE VITAMIN-D; AMBULATORY PERITONEAL-DIALYSIS; PARATHYROID-HORMONE LEVELS; ETHANOL INJECTION THERAPY; BETA(2)-MICROGLOBULIN ADSORPTION COLUMN; CHRONIC-HEMODIALYSIS PATIENTS; SERUM ALKALINE-PHOSPHATASE;

D O I：

10.1111/1744-9987.12058

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：247 / 288

页数：42

共 50 条

[41] Current therapeutic approach of chronic kidney disease-mineral and bone disorder
Zaimi, Maria
Grapsa, Eirini
THERAPEUTIC APHERESIS AND DIALYSIS, 2024, 28 (05) : 671 - 689
[42] THE ASSOCIATION OF CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER AND CARDIOVASCULAR RISK
Eddington, Helen
Kalra, Philip A.
JOURNAL OF RENAL CARE, 2010, 36 : 61 - 67
[43] Chronic kidney disease-mineral bone disorder and fractures in predialysis patients
Fernandes, Bernardo
Lopes, Mariana Diz
Neto, Ricardo
Frazao, Joao M.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
[44] Treatment of chronic kidney disease-mineral bone disorder and vascular complications
Moe, Sharon M.
THERAPEUTIC APHERESIS AND DIALYSIS, 2006, 10 : S2 - S15
[45] Role of sclerostin in the pathogenesis of chronic kidney disease-mineral bone disorder
Asamiya Y.
Tsuchiya K.
Nitta K.
Renal Replacement Therapy, 2 (1) : 1 - 8
[46] Chronic kidney disease-mineral bone disorder and fractures in predialysis patients
Fernandes, Bernardo
Lopes, Mariana Diz
Neto, Ricardo
Frazao, Joao M.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1105 - I1106
[47] OSTEOPROTEGERIN AS AN EARLY SIGN OF CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER
Grskovic, Antun
Celic, Tanja
Spanjol, Josip
Markic, Dean
Devcic, Bosiljka
Bobinac, Dragica
Racki, Sanjin
ACTA CLINICA CROATICA, 2023, 62 : 46 - 52
[48] Chronic Kidney Disease-Mineral Bone Disorder: New Understandings of an Old Disease
Lerma, Edgar V.
CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM, 2012, 10 (03): : 117 - 118
[49] Bone health in chronic kidney disease-mineral and bone disease
Gal-Moscovici, Anca
Sprague, Stuart M.
ADVANCES IN CHRONIC KIDNEY DISEASE, 2007, 14 (01) : 27 - 36
[50] KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword
Wheeler, David C.
Winkelmayer, Wolfgang C.
KIDNEY INTERNATIONAL SUPPLEMENTS, 2017, 7 (01): : 12 - 12

← 1 2 3 4 5 →